Close
Achema middle east
swop processing & packaging

Mylan Pharmaceuticals launches Fenofibrate Capsules

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Biopharmaceutical Formulation Stability Solutions

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Innovative Formulation Strategies for Poorly Soluble Drugs

The pharmaceutical industry confronts a formidable obstacle that threatens...

Mylan Pharmaceuticals, a subsidiary of global pharmaceutical company Mylan, has launched Fenofibrate Capsules USP, 43 mg and 130 mg.

Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings’ Antara Capsules, are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

In addition, Fenofibrate Capsules reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Fenofibrate has not been shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus, according to Mylan,

According to IMS Health, Mylan currently has 184 ANDAs pending FDA approval representing $80.7bn in annual sales, out of which 36 pending ANDAs are potential first-to-file opportunities, representing $21.1bn in annual brand sales, for the 12 months ending 30 June 2012.

 

Latest stories

Related stories

Biopharmaceutical Formulation Stability Solutions

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Innovative Formulation Strategies for Poorly Soluble Drugs

The pharmaceutical industry confronts a formidable obstacle that threatens...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »